申请人:Warner-Lambert Company
公开号:US04180675A1
公开(公告)日:1979-12-25
The present invention relates to 15-cycloalkyl-prostaglandins of the formula: ##STR1## wherein A represents a grouping of the formula: ##STR2## W represents ethylene or trans-vinylene, X represents ethylene or cis-vinylene, Y represents ethylene or trans-vinylene, R represents a hydrogen atom or a straight- or branched-chain alkyl group containing from 1 to 12 carbon atoms, R.sup.1 represents a hydrogen atom or a methyl or ethyl group, R.sup.2 represents a straight- or branched-chain alkyl group containing from 2 to 8 carbon atoms or a phenyl group unsubstituted or substituted by an alkyl group containing from 1 to 3 carbon atoms, R.sup.3 represents a hydrogen atom or a straight- or branched-chain alkyl group containing from 1 to 3 carbon atoms, and n represents 4 or 5 and cyclodextrin clathrates of such acids and esters and, when R represents a hydrogen atom, non-toxic salts thereof. These new compounds exhibit characteristic prostaglandin-like activities.
本发明涉及公式为:##STR1##的15-环烷基前列腺素,其中A表示公式为:##STR2##的基团,W表示乙烯或顺式-乙烯基,X表示乙烯或顺式-乙烯基,Y表示乙烯或顺式-乙烯基,R表示氢原子或含1至12个碳原子的直链或支链烷基,R.sup.1表示氢原子或甲基或乙基基团,R.sup.2表示含2至8个碳原子的直链或支链烷基或未取代或取代有含1至3个碳原子的烷基的苯基,R.sup.3表示氢原子或含1至3个碳原子的直链或支链烷基,n表示4或5的环糊精包合物和这些酸和酯的,当R表示氢原子时,其无毒盐。这些新化合物表现出特征性的前列腺素样活性。